(MedPage Today) -- An oral enzyme supplement appeared to reduce symptom severity for adults with irritable bowel syndrome (IBS), a prospective, single-arm study showed. Among over 400 patients taking the enzyme blend targeting FODMAPs (fermentable...
(MedPage Today) -- Republican officials and conservative social media users spread unfounded rumors in recent days that state Rep. James Talarico, the Democratic nominee in a competitive Texas Senate race, had suffered a mental health crisis....
(MedPage Today) -- Note that some links may require registration or subscription. Actress Selma Blair, who has multiple sclerosis, was accused of kicking a nurse at a hospital following an alleged assault of two flight attendants on a flight from...
Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or external calibration. The post Happy Health’s Cuffless BP Device Wins FDA Clearance appeared first on MedCity News .
Roche gains global rights to a Rona Therapeutics RNA interference drug designed to target ALK7, a genetically validated target for obesity and other metabolic indications. The growing field of companies pursuing ALK7 includes GSK and Arrowhead Pharmaceuticals. The post Roche…
Medicare policy should be transparent and include appropriate notice and stakeholder input. And when a contractor gets it wrong, there should be a clear and rapid way to stop the harm to patients, their relationship with their doctor and the…
Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh, Carson, Anderson & Stowe. Hello, BlackRock.
Helen Branswell, STAT's infectious disease reporter who earned the respect of experts and public health officials with her accessible, prescient dispatches, has died at age 69.
Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.
In this edition of Health Care Inc., we examine the controversy around the health plan covering North Carolina's public workers and retirees, and more.